Close Menu

This story has been updated with information from the company's earnings call

NEW YORK – Meridian Bioscience reported on Friday morning a 75 percent year-over-year jump in its fiscal third quarter revenues, driven by 313 percent revenue growth in its life science business.

The Cincinnati-based life science and diagnostics firm recorded total revenues of $84.8 million compared to $48.4 million a year ago, beating analysts' average estimate for revenues of $66 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.